Nov 05, 2024
1:50
For every 50 shares held, investors received 1. The price per share adjusted from $0.10 to $0.00.
The split itself did not change the total investment value.
Qualigen Therapeutics, Inc. (QLGN) trades on the NASDAQ Capital Market in the Biotechnology industry.
Qualigen Therapeutics, Inc. company overviewThe latest split shown was on November 5, 2024. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
This history records 4 reverse splits between March 23, 2018 and November 5, 2024.